Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
cancer treatment regimen
|
| gptkbp:contrastsWith |
gptkb:ATRA_plus_arsenic_trioxide
|
| https://www.w3.org/2000/01/rdf-schema#label |
ATRA plus chemotherapy
|
| gptkbp:improvesSurvival |
acute promyelocytic leukemia patients
|
| gptkbp:includesDrug |
gptkb:all-trans_retinoic_acid
chemotherapy agents |
| gptkbp:mechanismOfAction |
cytotoxicity to leukemic cells
induces differentiation of leukemic cells |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
infections
differentiation syndrome myelosuppression |
| gptkbp:standardOfCare |
gptkb:acute_promyelocytic_leukemia
|
| gptkbp:usedFor |
gptkb:acute_promyelocytic_leukemia
|
| gptkbp:bfsParent |
gptkb:acute_promyelocytic_leukemia
|
| gptkbp:bfsLayer |
6
|